RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial
Clinical trial NCT01127542 · TERMINATED
Trial details
- NCT number
- NCT01127542
- Sponsor
- The Christie NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.